Advanced NanoTherapies Closes $31M Series B Financing for Dual-Drug Nanoparticle-Coated Balloon Platform
Advanced NanoTherapies has secured over $31 million in a Series B funding round to advance its dual-drug nanoparticle-coated balloon platform, which aims to improve vascular treatment outcomes. The financing will support the approval of an Investigational Device Exemption (IDE) and clinical development for coronary applications as well as expansion into below-the-knee peripheral disease.
Topics: Clinical Trials Drug-Coated Balloons Medical Technology Series B Financing